WallStreetZenWallStreetZen

NASDAQ: ABEO
Abeona Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ABEO past revenue growth

How has ABEO's revenue growth performed historically?
Company
-68.08%
Industry
69.78%
Market
14.1%
ABEO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ABEO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ABEO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ABEO earnings and revenue history

Current Revenue
$1.1M
Current Earnings
-$31.8M
Current Profit Margin
-2,977%

ABEO Return on Equity

Current Company
-157%
Current Industry
-18%
Current Market
30.8%
ABEO's Return on Equity (-157%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ABEO announces earnings.

ABEO Return on Assets

Current Company
-63.3%
Current Industry
0.9%
ABEO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ABEO Return on Capital Employed

Current Company
-59.36%
Current Industry
14.1%
ABEO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABEO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ABEO$1.07M-$22.91M-$31.79M-2.01%N/A
INAB$0.00-$28.44M-$29.90MN/AN/A
RZLT$0.00-$47.73M-$48.48MN/AN/A
CRDF$395.00k-$38.64M-$38.96M-5.00%N/A
IPA$14.70M-$14.82M-$18.89M+6.61%N/A
View Top Biotech Stocks

Abeona Therapeutics Earnings & Revenue FAQ

What were ABEO's earnings last quarter?

On Invalid Date, Abeona Therapeutics (NASDAQ: ABEO) reported Q1 2023 earnings per share (EPS) of -$0.54, up 85.79% year over year. Total Abeona Therapeutics earnings for the quarter were -$9.11 million. In the same quarter last year, Abeona Therapeutics's earnings per share (EPS) was -$3.80.

If you're new to stock investing, here's how to buy Abeona Therapeutics stock.

What was ABEO's earnings growth in the past year?

As of Q2 2023, Abeona Therapeutics's earnings has grown year over year. Abeona Therapeutics's earnings in the past year totalled -$31.79 million.

What was ABEO's revenue last quarter?

On Invalid Date, Abeona Therapeutics (NASDAQ: ABEO) reported Q1 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Abeona Therapeutics's revenue was $346.00 thousand.

What was ABEO's revenue growth in the past year?

As of Q2 2023, Abeona Therapeutics's revenue has grown -68.08% year over year. This is 137.86 percentage points lower than the US Biotechnology industry revenue growth rate of 69.78%. Abeona Therapeutics's revenue in the past year totalled $1.07 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.